Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AY Pharmaceuticals
Chuo-ku, Tokyo, Japan
- Ownership
- Private
- Development stage
- Other
01
Overview
AY Pharmaceuticals is a leading provider of infusion and dialysis products in Japan, offering a broad portfolio of parenteral nutrition (e.g., Pareplus), amino acid infusions (e.g., Morihepamin), and diagnostic agents. It also serves as the manufacturing center for biosimilars such as YLB113 (etanercept) and Nesp BS (darbepoetin alfa) within the Yoshindo group.
- Therapeutic areas
- ImmunologyNephrologyGastroenterologyMetabolic Disorders
- Modalities
- Small moleculeRecombinant protein
- Industry
- Biotech
02
Partnerships
Teijin PharmaEA PharmaPanGen BiotechHK inno.NLupin
Beyond the preview
Go deeper on AY Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on AY Pharmaceuticals.